We are live on ! Find out more
ARCK

Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock
ARCK

Delisted

ARCK was delisted on the 12th of January, 2023.

Back to rankings

1 hedge funds and large institutions have $0 invested in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, increasing their positions, 0 reducing their positions, and 2 closing their positions.

New
Increased
Maintained
Reduced
Closed

50% less funds holding

Funds holding: 2 → 1 (-1)

50% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 2

100% less capital invested

Capital invested by funds: $18.7K → $0 (-$18.7K)

Holders
1
Holders Change
-1
Holders Change %
-50%
% of All Funds
0.02%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
–
Reduced
–
Closed
2
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
TRCT
Tower Research Capital (TRC)
New York
+$235

Top Sellers

Rank Fund Capital Flow
1
WAM
Wolverine Asset Management
Illinois
-$14.5K
2
UBS Group
UBS Group
Switzerland
-$4.2K
Name Holding Trade Value Shares
Change 		Change in
Stake
WAM
1
Wolverine Asset Management
Illinois
– -$14.5K -1,333 Closed
UBS Group
2
UBS Group
Switzerland
– -$4.2K -387 Closed
TRCT
3
Tower Research Capital (TRC)
New York
– +$235 +18 New

ARCK Hedge Fund Activity: Q1 2023 in Review

1 of the 6,277 institutional investors tracked by Wall St. Rank reported a position in Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) for Q1 2023, worth a combined $0 — down 100% from $18.7K a quarter earlier.

Sellers outnumbered buyers: 2 funds closed out of ARCK and 1 opened new positions — a net loss of 1 holder — while 0 trimmed existing stakes and 0 added.

The largest buyer was Tower Research Capital (TRC), opening a new position worth an estimated $235. The largest seller was Wolverine Asset Management, exiting entirely with an estimated $14.5K sold.

  • 1 institutional investor held Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock (ARCK) as of Q1 2023, down from 2 in Q4 2022.
  • Funds reported $0 of Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock stock for Q1 2023, down 100% quarter-over-quarter.
  • 1 fund opened new Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock positions in Q1 2023 and 2 closed out, a net change of -1 holder.
  • The largest Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock buyer in Q1 2023 was Tower Research Capital (TRC), an estimated $235 added.
  • The largest Arbor Rapha Capital Bioholdings Corp. I Class A Common Stock seller in Q1 2023 was Wolverine Asset Management, an estimated $14.5K sold.

Based on aggregated 13F filings for Q1 2023.